- Poster presentation
- Open Access
Vasopressin, epinephrine, and methylprednisolone in inhospital cardiac arrest
Critical Care volume 11, Article number: P324 (2007)
Combined vasopressin, epinephrine, and methylprednisolone during cardiopulmonary resuscitation (CPR) may improve survival in inhospital cardiac arrest.
Ninety-one adults with cardiac arrest were randomized to receive either vasopressin (20 IU/CPR cycle for five cycles) plus epinephrine (1 mg/CPR cycle) plus methylprednisolone (single dose = 40 mg) or placebo plus epinephrine (1 mg/CPR cycle) plus placebo. Primary endpoints were return of spontaneous circulation (ROSC) for ≥15 minutes, and survival to discharge either to home or to a rehabilitation facility.
Study group patients had higher rates of ROSC (37/44 vs 24/47; P < 0.01) and discharge either to home or to a rehabilitation facility (7/44 vs 1/47; P < 0.05). Sixty-day survival was improved in the study group (Figure 1).
Combination treatment improves survival in inhospital cardiac arrest.
About this article
Cite this article
Mentzelopoulos, S., Katsios, N., Papastylianou, A. et al. Vasopressin, epinephrine, and methylprednisolone in inhospital cardiac arrest. Crit Care 11, P324 (2007). https://0-doi-org.brum.beds.ac.uk/10.1186/cc5484
- Public Health
- Group Patient
- Single Dose